A report released in February by US-based Research and Markets addresses the shift in China away from low volume, high value manufacturing as a major catalyst for the increasing growth rate of China’s pharmaceutical market. The country now holds, at minimum, an 8 – 10% market share globally. The report goes on to state that greater technological advancements could quickly …
What is the Coronavirus? The 2019-nCoV virus – more commonly known to the public as simply ‘coronavirus’ or ‘Wuhan coronavirus’ – has dominated international news over the recent weeks, as fears have mounted over the potential lethality of the disease. Fortunately, such fears appear to be thus far unfounded, as the disease sits at around a 2.2% mortality rate, with …
If you’ve only recently taken an interest in the healthcare sector in China, you may be confused by some of the acronyms you see floating around, and wonder why there seem to be multiple agencies doing the same jobs. You’ll be pleased to hear that the confusion in some English language publications mainly results from a change of name and …
The Chinese pharmaceutical market sees another significant victory in recent weeks as it is announced that China has conditionally approved the first new Alzheimer’s drug to hit the global market in 17 years, and it will be distributed worldwide for long-term testing. The seaweed-derived drug GV-971, more colloquially known as Oligomannate, appears to improve cognition in patients with mild to …
The emergence of a new, potentially dangerous coronavirus in the city of Wuhan in China’s Hubei province has sparked a flurry of articles in the international media and widespread discussion on social media, much of it poorly informed or coloured by politics. With epidemiologists from multiple nations working together to tackle the outbreak, cooperation and the clear exchange of information …
